23 October 2012
Responding to the latest Cancer Survival Statistics for England released today by Office National Statistics, Charlotte Potter, Policy Manager of Macmillan Cancer Support, says:
“Yet again survival for rarer cancer is trailing behind the more common cancers. This proves just how vital it is for the NHS to be measured against and held to account for improving cancer survival for all cancers not just the more common ones*.
“Nobody chooses the type of cancer they have. Each cancer patient deserves to be given the best chance of survival.
“The Government and the NHS Commissioning Board must listen and ensure that one year and five year survival indicators for all cancers are included in their relevant outcomes frameworks.
For further information, please contact:
Andrea Shufflebotham, Senior Media & PR Officer
0207 840 4689 (out of hours 07801 307068)
Notes to Editors:
*Currently the NHS is only measured against only breast, lung and colorectal cancer survival. Macmillan would like to see this widened to include all cancers.
About Macmillan Cancer Support
Cancer is the toughest fight most of us will ever face. But you don’t have to go through it alone. The Macmillan team is with you every step of the way.
We are the nurses and therapists helping you through treatment. The experts on the end of the phone. The advisers telling you which benefits you’re entitled to. The volunteers giving you a hand with the everyday things. The campaigners improving cancer care. The fundraisers who make it all possible.
We are Macmillan Cancer Support.